CNXC — Concentrix Income Statement
0.000.00%
- $3.21bn
- $7.80bn
- $9.62bn
- 95
- 92
- 84
- 100
Annual income statement for Concentrix, fiscal year end - November 30th, USD millions except per share, conversion factor applied.
2020 November 30th | 2021 November 30th | 2022 November 30th | 2023 November 30th | 2024 November 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4,720 | 5,587 | 6,324 | 7,115 | 9,619 |
Cost of Revenue | |||||
Gross Profit | 1,662 | 1,969 | 2,257 | 2,578 | 3,449 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 4,411 | 5,015 | 5,684 | 6,509 | 9,023 |
Operating Profit | 309 | 572 | 640 | 605 | 596 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 268 | 556 | 605 | 408 | 299 |
Provision for Income Taxes | |||||
Net Income After Taxes | 165 | 406 | 436 | 314 | 251 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 165 | 406 | 435 | 314 | 251 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 165 | 400 | 428 | 308 | 242 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.64 | 7.99 | 8.75 | 7.51 | 6.31 |
Dividends per Share |